Downregulation of the kidney glucagon receptor, essential for renal function and systemic homeostasis, contributes to chronic kidney disease
Eligibility is a clinical judgment built from body mass index thresholds described in regulatory labeling, the presence or absence of weight-related health conditions, a screen for contraindications, and an assessment of whether medication fits a patients broader health picture
Care 29, 733738
EXSCEL compared extended release exenatide to placebo in 14,752 patients with T2DM and established CV disease or CV risk factors only [18]
Following PSM, the number of patients with SMI using APs matched with Michigan was 3726 in California, 2550 in Colorado, 1838 in Florida, 2423 in Illinois, and 1308 in Wisconsin